Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Vazquez Martin, Alejandro ^a,b   Cufi, Sílvia ^a,b   Lopez Bonet, Eugeni ^b,c   Corominas Faja, Bruna ^a,b   Oliveras Ferraros, Cristina ^a,b   Martin Castillo, Begoña ^a,b   Menendez, Javier A ^a,b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN; OCTAMER TRANSCRIPTION FACTOR 4;

ANIMAL; ARTICLE; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PLURIPOTENT STEM CELL; TERATOMA;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HYPOGLYCEMIC AGENTS; INDUCED PLURIPOTENT STEM CELLS; METFORMIN; MICE; MICE, INBRED C57BL; MICE, NUDE; OCTAMER TRANSCRIPTION FACTOR-3; TERATOMA;

EID: 84871735126     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00964     Document Type: Article

References (30)

1. Brickman, J.M. & Burdon, T. G. Pluripotency and tumorigenicity. Nat Genet 32, 557-558 (2002). (Pubitemid 35435163)
2. Knoepfler, P. S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27, 1050-1056 (2009).
3. Blum, B. & Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 100, 133-158 (2008). (Pubitemid 351932182)
4. Ben-David, U. & Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11, 268-277 (2011).
5. Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N. & Struhl, K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69, 7507-7511 (2009).
6. Vazquez-Martin, A., Oliveras-Ferraros, C., Del Barco, S., Martin-Castillo, B. & Menendez, J. A. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat 126, 355-364 (2011).
7. Song, C. W. et al. Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep 3, 362 (2012).
8. Bao, B. et al. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prev Res (Phila) 5, 355-364 (2012).
9. Chae, H. D., Lee, M. R. & Broxmeyer, H. E. 5-Aminoimidazole-4- carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation. Stem Cells 30, 140-149 (2012).
10. Hardie, D. G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes & Dev 25, 1895-1908 (2011).
11. Vazquez-Martin, A. et al. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells. Cell Cycle 11, 974-989 (2012).
12. Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J 22, 659-661 (2008). (Pubitemid 351348146)
13. Blum, B., Bar-Nur, O., Golan-Lev, T. & Benvenisty, N. The anti-apoptotic gene surviving contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 27, 281-287 (2009).
14. Menendez, S., Camus, S., Herreria, A., Paramonov, I., Morera, L. B. & Collado, M. et al. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Aging Cell 11, 41-50 (2012).
15. Lengner, C. J., Welstead, G. G. & Jaenisch, R. The pluripotency regulator Oct4: a role in somatic stem cells? Cell Cycle 7, 725-728 (2008). (Pubitemid 351520033)
16. Jung, J. W., Park, S. B., Lee, S. J., Seo, M. S., Trosko, J. E. & Kang, K. S. Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. PLoS One 6, e28068 (2011).
17. Wang, J. et al. Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation. Cell Stem Cell 11, 23-35 (2012).
18. Menendez, J. A. & Vazquez-Martin, A. Rejuvenating regeneration: Metformin activates endogenous stem cells. Cell Cycle 11, 3521-2 (2012).
19. Martin-Castillo, B., Vazquez-Martin, A., Oliveras-Ferraros, C. &Menendez, J. A. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle 9, 1057-1064 (2010).
20. Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Martin-Castillo, B. & Menendez, J. A. Metformin and energy metabolism in breast cancer: from insulin physiology to Tumour-initiating stem cells. Curr Mol Med 10, 674-691 (2010).
21. Del Barco, S. et al.Metformin: multi-faceted protection against cancer. Oncotarget 2, 896-917 (2011).
22. Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O. & McKnight, S. L. Dependence of mouse embryonic stem cells on threonine catabolism. Science 325, 435-439 (2009).
23. Corominas-Faja, B. et al.Metabolomic fingerprint reveals that metformin impairs one-carbon Metabolism in a manner similar to the antifolate class of Chemotherapy drugs. Aging (Albany NY) 4, 480-498 (2012).
24. Vazquez-Martin, A., Oliveras-Ferraros, C., del Barco, S., Martin-Castillo, B. & Menendez, J. A. The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy. Ann Oncol 20, 592-595 (2009).
25. Prigione, A. et al.Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells 29, 1338-1334 (2011).
26. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
27. Raya, A. et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59 (2009).
28. Liu, G. H. et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688-694 (2011).
29. Anisimov, V. N. Metformin for aging and cancer prevention. Aging (Albany NY) 2, 760-774 (2010).
30. Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Vellon, L., Joven, J. & Vazquez- Martin, A. Gerosuppressant metformin: less is more. Aging (Albany NY) 3, 348-362 (2011).